Early Identification and Treatment of Rare Cardiomyopathy Cohorts

NCT06794710 · clinicaltrials.gov ↗

NA

Phase

NOT_YET_RECRUITING

Status

300

Enrollment

OTHER

Sponsor class

Conditions

Hypertrophic Cardiomyopathy (HCM)
Dilated Cardiomyopathy (DCM)
Metabolic Cardiomyopathy
Restrictive Cardiomyopathy

Interventions

DRUG: diuretics, ACEIs/ARBs, beta blockers, positive inotropic drugs, MRAs, SGLT2i, retinoids
BEHAVIORAL: Close follow-up
BEHAVIORAL: early rehabilitation guidance

Sponsor

RenJi Hospital